Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1

Interventions

Cyclophosphamide 38 fludarabine 30 Rituximab 26 obinutuzumab 10 Bendamustine Hydrochloride 10 fludarabine phosphate 9 pembrolizumab 8 Specimen Handling 7 Etoposide 7 venetoclax 6 Vincristine 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 Leukapheresis 6 Lenalidomide 6 ibrutinib 5 Inotuzumab Ozogamicin 5 Immunotherapy, Adoptive 5 Doxorubicin 5 Biopsy 5 ublituximab 4 tazemetostat 4 glofitamab 4 Interleukin-2 4 Dexamethasone 4 Cytarabine 4 pomalidomide 3 polatuzumab vedotin 3 Radiation 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, B-Cell × spebrutinib × Clear all

NCT01766583 2018-03-07

CLEAR

The Lymphoma Academic Research Organisation

Phase 1 Completed

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡